ロード中...
The Immunogenicity and Safety of the Live-attenuated SA 14-14-2 Japanese Encephalitis Vaccine Given with a Two-dose Primary Schedule in Children
Effective and tolerable vaccination is an essential strategy to prevent Japanese encephalitis (JE) in endemic areas. Although the live attenuated SA 14-14-2 JE vaccine (LAJEV) has been widely used since its introduction, the systemic data of LAJEV was very rarely available in Korea. We conducted the...
保存先:
| 出版年: | J Korean Med Sci |
|---|---|
| 主要な著者: | , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
The Korean Academy of Medical Sciences
2015
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4414646/ https://ncbi.nlm.nih.gov/pubmed/25931793 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3346/jkms.2015.30.5.612 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|